Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Cancer Cachexia 1

Interventions

RC-1291 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Cancer Cachexia × RC-1291 × Clear all
NCT00378131 2013-09-02

Placebo Controlled, Randomized Safety and Efficacy Study of RC-1291 in Cancer Anorexia/Cachexia

Helsinn Therapeutics (U.S.), Inc

Phase 2 Completed
51 enrolled

Cancer Cachexia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡